International Biotechnology Trust plc (IBT) — Capital Reinvestment Ratio

Latest as of August 2025: 1.00x

International Biotechnology Trust plc (IBT) has a Capital Reinvestment Ratio of 1.00x as of August 2025, meaning it reinvests 1% of its operating cash flow (GBX31.30 Million) in capital expenditures (GBX31.30 Million). Check IBT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.00x
Capex / Operating Cash Flow

Operating Cash Flow

GBX31.30 Million
GBX

Capital Expenditures

GBX31.30 Million
GBX

Data as of

Aug 2025
Most recent filing

International Biotechnology Trust plc Capital Reinvestment Ratio (2024–2025)

This chart tracks International Biotechnology Trust plc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see International Biotechnology Trust plc (IBT) cash conversion ratio.

Annual Capital Reinvestment Ratio for International Biotechnology Trust plc (2024–2025)

Year-by-year Capital Reinvestment Ratio for International Biotechnology Trust plc from 2024 to 2025. See International Biotechnology Trust plc (IBT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (GBX) Capital Expenditures YoY Change
2025 1.00x GBX28.63 Million GBX28.63 Million ▲ +0.0%
2024 1.00x GBX45.35 Million GBX45.35 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow